HDAC3 and glioblastoma: During the GBM process, hyperactivity of HDAC3, 5, and 9 is expressed in IL-4-induced M2 GAMs (101, 123) that increase the levels of TGFβ and IL-10, resulting in exacerbating the immunosuppressive capacity of GBM tumor cells (124).